Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
May 09 04:00PM ET
4.47
Dollar change
0.00
Percentage change
0.00
%
IndexRUT P/E- EPS (ttm)-5.54 Insider Own4.98% Shs Outstand139.51M Perf Week-5.10%
Market Cap627.59M Forward P/E- EPS next Y-0.04 Insider Trans0.00% Shs Float133.41M Perf Month4.93%
Income-545.06M PEG- EPS next Q-0.85 Inst Own58.08% Short Float33.68% Perf Quarter17.94%
Sales983.71M P/S0.64 EPS this Y86.63% Inst Trans3.21% Short Ratio6.58 Perf Half Y-36.95%
Book/sh-5.14 P/B- EPS next Y94.47% ROA-26.50% Short Interest44.93M Perf Year-53.05%
Cash/sh4.12 P/C1.08 EPS next 5Y- ROE- 52W Range3.53 - 11.36 Perf YTD-6.88%
Dividend Est.- P/FCF- EPS past 5Y11.55% ROI- 52W High-60.65% Beta1.42
Dividend TTM- Quick Ratio0.67 Sales past 5Y513.29% Gross Margin67.00% 52W Low26.54% ATR (14)0.26
Dividend Ex-DateDec 13, 2007 Current Ratio0.70 EPS Y/Y TTM34.19% Oper. Margin-56.11% RSI (14)50.53 Volatility5.65% 5.52%
Employees1543 Debt/Eq- Sales Y/Y TTM-50.36% Profit Margin-55.41% Recom2.50 Target Price15.40
Option/ShortYes / No LT Debt/Eq- EPS Q/Q36.83% Payout- Rel Volume0.65 Prev Close4.47
Sales Surprise-7.22% EPS Surprise1.32% Sales Q/Q-18.48% EarningsMay 10 BMO Avg Volume6.83M Price4.47
SMA204.37% SMA50-4.08% SMA200-23.55% Trades Volume4,533,199 Change0.00%
Date Action Analyst Rating Change Price Target Change
Aug-09-23Upgrade B. Riley Securities Neutral → Buy $15
Apr-20-23Downgrade TD Cowen Outperform → Market Perform $55 → $10
Mar-01-23Downgrade B. Riley Securities Buy → Neutral $29 → $10
Jan-09-23Reiterated B. Riley Securities Buy $74 → $37
Dec-30-22Reiterated H.C. Wainwright Buy $207 → $110
Dec-02-22Initiated Jefferies Hold
Sep-22-22Downgrade JP Morgan Neutral → Underweight $132 → $27
May-20-22Initiated BofA Securities Underperform $35
Feb-23-22Reiterated B. Riley Securities Buy $315 → $265
Feb-22-22Resumed Jefferies Buy $198
Today 07:48AM
07:47AM
07:30AM
07:27AM
06:53AM
06:34AM Loading…
06:34AM
05:14AM
05:10AM
05:03AM
02:35AM
02:19AM
02:15AM
02:09AM
02:00AM
02:00AM
05:06AM Loading…
May-09-24 05:06AM
May-07-24 10:00AM
09:25AM
May-06-24 03:03PM
01:58PM
01:45PM
08:18AM
06:47AM
06:29AM
06:22AM
Apr-30-24 06:15PM
Apr-29-24 08:10AM
Apr-25-24 06:00AM
Apr-21-24 05:08AM
Apr-19-24 11:02AM
01:17PM Loading…
Apr-15-24 01:17PM
10:52AM
06:00AM
12:44AM
12:12AM
Apr-13-24 04:22PM
Apr-12-24 06:35AM
Apr-11-24 09:12AM
Apr-09-24 04:30PM
Apr-03-24 01:18PM
Apr-02-24 10:15AM
Apr-01-24 08:00AM
Mar-29-24 11:30AM
Mar-13-24 07:07AM
Mar-09-24 01:59AM
Mar-07-24 02:52PM
05:28AM
Mar-06-24 05:13PM
Mar-05-24 01:05PM
06:30AM
Mar-04-24 05:03AM
Mar-01-24 05:25AM
Feb-29-24 04:02PM
11:13AM
11:12AM
Feb-28-24 10:49PM
12:58PM
10:38AM
10:16AM
10:00AM
09:52AM
09:10AM
09:00AM
08:34AM
08:17AM
08:11AM
08:11AM
08:00AM
08:00AM
Feb-27-24 05:30AM
Feb-26-24 02:46AM
Feb-23-24 07:35AM
Feb-22-24 03:52PM
01:39PM
12:39PM
11:09AM
09:47AM
06:21AM
06:10AM
06:00AM
06:00AM
Feb-20-24 10:00AM
09:25AM
Feb-15-24 04:01PM
05:17AM
Feb-11-24 05:00PM
Feb-05-24 09:20AM
Feb-03-24 08:07PM
05:35AM
Feb-01-24 05:04AM
Jan-31-24 01:33PM
11:17AM
08:22AM
08:15AM
08:08AM
05:06AM
Jan-29-24 08:15AM
Jan-28-24 07:25AM
03:15AM
Jan-27-24 08:45AM
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
O'Hara ElaineEVP, Chief Strategy OfficerMar 01 '24Option Exercise5.3919,600105,64419,600Mar 05 07:30 PM
Dubovsky FilipPresident, R&DDec 14 '23Option Exercise5.692,83316,12055,150Dec 18 05:00 PM
Dubovsky FilipPresident, R&DNov 05 '23Option Exercise7.061,4009,88452,994Nov 07 05:30 PM
Dubovsky FilipPresident, R&DSep 16 '23Option Exercise7.7112,64497,48557,702Sep 19 05:16 PM
Dubovsky FilipPresident, R&DJun 16 '23Option Exercise8.044,15533,40647,065Jun 21 04:40 PM